v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-controlling interests
Shares outstanding, beginning balance (in shares) at Dec. 31, 2023   139,705        
Equity, beginning balance at Dec. 31, 2023 $ 634,716 $ 1,397 $ 925,623 $ (18,826) $ (274,999) $ 1,521
Share-based compensation expense 3,670   3,670      
Net loss (28,690)       (28,543) (147)
Reclassification of warrants from liability classified to equity classified 10   10      
Other comprehensive income (26,044)     (26,044)    
Shares outstanding, ending balance (in shares) at Mar. 31, 2024   139,705        
Equity, ending balance at Mar. 31, 2024 $ 583,662 $ 1,397 929,303 (44,870) (303,542) 1,374
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024 155,928 155,928        
Equity, beginning balance at Dec. 31, 2024 $ 188,762 $ 1,559 971,416 (58,975) (725,238) 0
Share-based compensation expense 4,242   4,242      
Net loss (16,239)       (16,239)  
Exercise of stock options (in shares)   10        
Exercise of stock options 0          
Preferred dividends and accretion (891)   (891)      
Other comprehensive income $ 26,065     26,065    
Shares outstanding, ending balance (in shares) at Mar. 31, 2025 155,938 155,938        
Equity, ending balance at Mar. 31, 2025 $ 201,939 $ 1,559 $ 974,767 $ (32,910) $ (741,477) $ 0